IRIS
LIAKOULI, Vasiliki
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.505
NA - Nord America 3.286
AS - Asia 2.901
SA - Sud America 665
AF - Africa 32
Totale 12.389
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.085
US - Stati Uniti d'America 3.221
SG - Singapore 1.000
IE - Irlanda 607
CN - Cina 586
HK - Hong Kong 572
BR - Brasile 559
VN - Vietnam 391
GB - Regno Unito 250
KR - Corea 180
DE - Germania 152
IT - Italia 133
GR - Grecia 113
SE - Svezia 43
AR - Argentina 42
IN - India 39
UA - Ucraina 38
CA - Canada 25
FR - Francia 24
ID - Indonesia 23
MX - Messico 22
BD - Bangladesh 20
TR - Turchia 20
EC - Ecuador 18
CO - Colombia 17
JP - Giappone 14
FI - Finlandia 13
PY - Paraguay 12
ZA - Sudafrica 12
IQ - Iraq 10
NL - Olanda 10
PK - Pakistan 10
UZ - Uzbekistan 8
AT - Austria 7
MA - Marocco 5
VE - Venezuela 5
BE - Belgio 4
CL - Cile 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
KE - Kenya 4
PE - Perù 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CR - Costa Rica 3
EG - Egitto 3
KZ - Kazakistan 3
NP - Nepal 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
ES - Italia 2
ET - Etiopia 2
IL - Israele 2
JO - Giordania 2
LV - Lettonia 2
PT - Portogallo 2
RO - Romania 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AO - Angola 1
BZ - Belize 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
SV - El Salvador 1
TH - Thailandia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 12.389
Salva come PNG Salva come JPEG
Città #
Moscow 1.377
Dublin 607
Hong Kong 567
Chicago 537
Santa Clara 479
Wilmington 441
Singapore 424
Falls Church 338
San Jose 179
Jacksonville 177
Seoul 175
Ho Chi Minh City 123
Beijing 114
Princeton 110
Roxbury 108
Ashburn 106
Chandler 103
Bremen 102
Hanoi 100
Medford 75
Hefei 71
Des Moines 41
Cambridge 35
São Paulo 35
Dallas 26
Naples 26
Da Nang 24
Rome 24
Los Angeles 21
Bengaluru 19
The Dalles 19
Rio de Janeiro 18
New York 16
Nanjing 15
Guangzhou 14
Belo Horizonte 13
Ann Arbor 12
Jinan 12
Curitiba 11
Guarulhos 11
Hải Dương 11
Brasília 10
Frankfurt am Main 10
Thái Bình 10
Atlanta 9
Caserta 9
Ottawa 9
Shanghai 9
Tianjin 9
Amsterdam 8
Biên Hòa 8
Hangzhou 8
Hebei 8
Mexico City 8
Montreal 8
Munich 8
Salvador 8
Shenyang 8
Tashkent 8
Baghdad 7
Boardman 7
Haiphong 7
Johannesburg 7
Ningbo 7
Thái Nguyên 7
Bắc Ninh 6
Changsha 6
Guayaquil 6
Kunming 6
Phủ Lý 6
Santo André 6
Athens 5
Bagnoli Irpino 5
Bogotá 5
Campinas 5
Caxias do Sul 5
Ciudad del Este 5
Council Bluffs 5
Dearborn 5
Falkenstein 5
Helsinki 5
Lấp Vò 5
Marsico Nuovo 5
Natal 5
Nha Trang 5
Ninh Bình 5
Nuremberg 5
Ribeirão Preto 5
Seattle 5
Woodbridge 5
Afragola 4
Aparecida de Goiânia 4
Asunción 4
Brussels 4
Chennai 4
Contagem 4
Fortaleza 4
Ha Long 4
Hortolândia 4
Houston 4
Totale 7.084
Salva come PNG Salva come JPEG
Nome #
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 1.386
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 183
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population 151
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 150
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 137
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 134
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 131
. FRI0437 Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from SSC Patients Induces an Anti Angiogenetic Effect, when Co-Cultured with Endothelial Cells. 124
AB0226 Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC). 121
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 118
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 118
Association of FASG670A gene polymorphism with systemic sclerosis. 118
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 117
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 116
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 116
Angiogenic cytokines and growth factors in systemic sclerosis 116
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 116
AB0244 Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 115
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome 114
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 112
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 110
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 106
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 105
Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? 103
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 101
Modificazioni della nitrossido-sintasi neuronale (nNOS) nella cute dei pazienti con sclerosi sistemica (SSc). 100
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset 100
AB0248 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 98
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 98
Interstitial lung disease in systemic sclerosis: current and future treatment 97
Cardiovascular disease in primary sjögren’s syndrome 95
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 95
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 94
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 94
IMPAIREMENT OF ENDOTHELIAL DIFFERENTIATION FROM MESENCHYMAL STEM CELLS (MSC) IN SYSTEMIC SCLEROSIS (SSC): A NEW TOOL IN PATHOGENETIC MECHANISM 94
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 93
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS 93
Interleukin-33 and its receptor st2 may serve as 'alarmin' system of the progressing damage to the skin and visceral organs of systemic sclerosis (ssc) patients 93
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 93
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 92
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 91
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 90
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients 90
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 90
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 90
AI-Based HRCT Quantification in Connective Tissue Disease-Associated Interstitial Lung Disease 89
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 89
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 88
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 88
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 88
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease. 88
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies 87
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 87
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI) 87
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 86
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 86
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 86
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implication. 86
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis 86
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease 85
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 85
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION 85
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 84
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 84
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine 83
Towards a consensus on the clinical applications and interpretations of the nailfold capillaroscopy standards in clinical practice: An initiative by the Egyptian Society of Microcirculation 82
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 82
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy 82
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 82
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 81
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 81
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 81
SAT0191 Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren's syndrome. 81
Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage 81
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 80
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor 80
Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma 80
Macitentan inhibits the transforming growth factor-βprofibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts. 80
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 79
SDF-1 expression in the skin of SSc patients. 79
Tocilizumab for the treatment of adult-onset Still's disease: results from a case series 79
The Vessels Contribute to Fibrosis in Systemic Sclerosis 78
Endothelial Progenitor Cells (EPC) characterization in systemic sclerosis (SSc) patients. 77
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 77
Methotrexate: an old new drug in autoimmune disease 77
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 76
Pigment epithelium derived factor secreted by ssc fibroblasts inhibits angio and vasculogenesis in vitro. 76
Cellular players in angiogenesis during the course of systemic sclerosis 75
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 75
Decreased expression of angiopoietin 1 on perivascular mesenchymalstemcells from SSc patients induces an anti angiogenic effect, when co-cultured with endothelial cells 75
Potential of stem cells in the treatment of rheumatic didease 75
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 75
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients 74
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 74
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 73
Development of a core domain set for nailfold capillaroscopy reporting 73
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 73
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 73
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 72
Use of Rituximab in the Management of Sjögren’s Syndrome 72
Totale 10.635
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.446 73 133 258 115 322 30 24 25 43 30 84 309
2022/20231.336 206 85 308 14 138 37 0 27 503 2 5 11
2023/2024356 18 9 3 7 160 10 6 12 4 7 9 111
2024/20251.826 1 0 3 31 240 283 292 165 231 395 111 74
2025/20266.939 258 343 425 482 652 3.766 270 254 224 128 105 32
2026/20273 3 0 0 0 0 0 0 0 0 0 0 0
Totale 12.618